Table 1.

Drug resistance patterns and number of variants in the study samples

Sample number	INH	RFP	SM	EMB	KM	AMK	OFLX	MXF	LFX	PZA	Number of variants
1	S	S	S	S	S	S	S	S	S	S	4
2	S	S	R	S	S	S	S	S	S	S	5
3	R	S	S	S	S	S	S	S	S	S	6
5	S	S	S	S	S	S	S	S	S	S	5
6	R	S	S	S	S	S	S	S	S	S	5
7	S	S	S	S	S	S	S	S	S	S	5
8	S	S	S	S	S	S	S	S	S	S	4
9	S	S	S	S	S	S	S	S	S	S	5
10	S	S	S	S	S	S	S	S	S	S	4
12	S	S	S	S	S	S	S	S	S	S	1
13	S	S	S	S	S	S	S	S	S	S	4
14	S	S	S	S	S	S	S	S	S	S	4
15	S	S	S	S	S	S	S	S	S	S	4
16	S	S	S	S	S	S	S	S	S	S	3
18	S	S	S	S	S	S	S	S	S	S	4
19	S	S	S	S	S	S	S	S	S	S	5
20	S	S	S	S	S	S	S	S	S	S	4
21	R	R	S	S	S	S	S	S	S	S	6
22	S	S	S	S	S	S	S	S	S	S	4
23	R	S	S	S	S	S	S	S	S	S	6
24	R	S	R	S	S	S	S	S	S	S	5
25	R	R	S	S	S	S	R	R	R	R	6
26	S	S	S	S	S	S	R	R	R	S	5
27	R	R	R	R	R	R	S	S	S	R	9
28	S	R	S	R	S	S	S	S	S	S	7
29	R	S	S	S	S	S	S	S	S	S	6
30	R	R	S	R	S	S	S	S	S	R	7
31	R	S	R	S	S	S	S	S	S	S	6
32	R	R	S	R	S	S	S	R	S	R	6
33	S	S	R	S	S	S	S	S	S	S	5
34	S	S	R	S	S	S	S	S	S	S	5
35	R	R	R	R	R	R	S	S	S	R	7
36	R	R	R	R	S	S	R	R	R	R	9
37	S	R	S	S	S	S	R	S	R	R	10
38	R	R	R	R	S	S	R	R	R	R	8
39	R	R	R	S	S	S	S	S	S	S	6

R resistance, S susceptible, INH isoniazid, RFP rifampin, SM streptomycin, EMB ethambutol, KM kanamycin, AMK amikacin, OFLX ofloxacin, MXL moxifloxacin, LFX levofloxacin, PZA pyrazinamide